News
Watch
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Health Systems|

Pharmacy Technician|

Dispensing Multiple Myeloma Meds

Dispensing Multiple Myeloma Meds

Episodes

Specialty:

All

Year:

All

EP. 1: The Economic Burden of Multiple Myeloma Treatment

March 29th 2019

EP. 2: Medicare Coverage of Oral Oncolytics

March 29th 2019

EP. 3: Oral Oncolytic Treatment Options for Multiple Myeloma

March 29th 2019

EP. 4: Pearl 1: The Use of Co-Pay Cards to Solve an Economic Burden

March 29th 2019

EP. 5: Pearl 1: Oral Parity Laws and Their Impact on Cost

March 29th 2019

EP. 6: The Risk Evaluation and Mitigation Strategies (REMS) Program

March 29th 2019

EP. 7: Pearl 3: Avoiding Delays During Prior Authorization Process

March 29th 2019

EP. 8: The Dispensing Capabilities of Pharmacies

March 29th 2019

EP. 9: The Role of Specialty Pharmacies in the Dispensing Process

March 29th 2019

EP. 10: Difficulties of the Multiple Myeloma Treatment Continuum

March 29th 2019

EP. 11: Pearl 4: Using a Collaborative Care Plan for the Treatment of MM

March 29th 2019

EP. 12: The Role of Payers in the Dispensing Process

March 29th 2019

EP. 13: The Future of Oral Oncolytics

March 29th 2019

EP. 14: The iStopMM Trial & Importance of Early Screening

March 29th 2019

Trending on Pharmacy Times

What Drives First-Line Immunotherapy Selection in NSCLC? Data, Payers, and Habit

FDA Grants Priority Review to Zanubrutinib Plus Rituximab for Previously Untreated MCL

AHA 2026: Insights on Oral PCSK9, Survodutide, and HF Care Come to Chicago

Gestational Diabetes: New Data on Treatment, Long-Term Risk

Amivantamab Becomes First FDA-Approved Therapy in 10 Years for Pretreated Recurrent or Metastatic HNSCC